With a study showing that only 1.3 per cent of Indian women aged 45 and above undergo screening for breast cancer, experts have called for immediate policy interventions, awareness campaigns and infrastructural advancements to encourage more women to opt for testing. A study published in the BMC Public Health indicate that India's breast cancer screening rates are among the lowest globally. While countries like the US and several European nations boast of screening rates above 80 per cent, India lags even behind some African nations, where 4.5 per cent of women undergo mammograms. Kerala leads with the highest screening rate in India at 4.5 per cent, followed by Karnataka (2.9 per cent) and Maharashtra (2.05 per cent), while Delhi records a shockingly low rate of less than 1 per cent. Experts attributed these abysmal statistics to multiple factors, including lack of awareness, social stigma, poor accessibility, and widespread misconceptions about mammography. Many women in India a
Writer and filmmaker Tahira Kashyap revealed her breast cancer has recurred seven years after remission, prompting questions about recurrence, symptoms, and treatment
In a social media post, writer & filmmaker Tahira Kashyap revealed that her breast cancer had relapsed after seven years; Ayushmann Khurrana called her 'my hero'. She was first diagnosed in 2018
The drug, vepdegestrant, failed to meaningfully delay cancer progression for all patients enrolled in the study but met its goals for a subset who have a specific genetic mutation
The WHO predicts a global surge in breast cancer cases and deaths. There are several reasons for this concerning tendency. The journal Nature Medicine published the results The WHO predicts a global s
Over 14.6 crore women across the country have been screened for breast cancer and 57,184 were diagnosed with the disease while 50,612 are receiving treatment, Union Health Minister J P Nadda said on Friday. Citing the national NCD portal data, he said in a written response to a question in Lok Sabha that more than nine crore women have been screened for cervical cancer out of which 96,747 were diagnosed with the disease and 86,196 are under treatment. The National NCD Portal was rolled out by the government in 2018 under NP-NCD for non communicable diseases (NCDs) screening and management and ensuring continuum of care for five common NCDs, including breast and cervical cancer. In order to prevent and control major NCDs like hypertension, diabetes, oral cancer, breast cancer and cervical cancer, the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) was launched by the Department of Health and Family Welfare, in 2010 with a focus on strengthening ..
Doctors, including the director of Tata Memorial Hospital, have refuted Sidhu's claim that his wife overcame cancer following a strict diet
The data also suggests that states such as Uttar Pradesh, Maharashtra, and West Bengal had the highest incidences of breast cancer in 2023
Delhi Metro on Thursday said it has withdrawn a poster on breast cancer awareness that asked women to check your oranges but the questions remained - does the metaphor obscure the message, does it help women in a cloistered society get comfortable or more awkward by sexualising a body part. Delhi Metro's action came after a day of raging debate on social media and outside it over the poster by YouWeCan Foundation, a non-profit organisation. The campaign timed with breast cancer awareness month in October featured AI-generated women on a bus holding oranges with a caption urging women to 'check your oranges once a month' for early detection. Though the poster was only on one train, commuters took screenshots, shared them widely and the issue quickly became an intense discussion topic on various platforms and forums. "Are the makers so starved of human decency that they would resort to comparing a vital body part to a fruit? How exactly are you teaching women to be comfortable talking
Breast cancer, a disease long associated with older age groups, has surged enormously in women aged below 50 in the last three decades, according to experts. Breast cancer is the most common type of cancer affecting women worldwide, as well as in India. The recent data from the Indian Council of Medical Research (ICMR) showed that breast cancer accounted for 28.2 per cent of cancers in women. Celebrities like Sonali Bendre, Tahira Kashyap, and Mahima Chaudhry who battled breast cancer under 50 and overcame the deadly disease with treatments. Dr Ashish Gupta, Chief of Medical Oncology at Unique Hospital Cancer Centre, who is spearheading the Cancer Mukt Bharat Campaign in India, said "Cancer is no longer the disease of older adults. It is increasingly seen among women in the younger age group, majorly under 50. The early onset of breast cancer is majorly due to genes, lifestyle factors such as poor nutrition, consumption of highly ultra-processed foods and a completely sedentary ..
The rise in breast cancer cases has been linked to various factors, including late pregnancies, family history, hormonal changes, and lifestyle habits like smoking and high stress
The overall survival, or OS rates, in the TROPION-Breast01 Phase III trial of datopotamab deruxtecan (Dato-DXd), did not achieve statistical significance
Hina Khan, battling with stage three breast cancer, recently developed mucositis which is a side-effect of chemotherapy. She requested her fans to share some advice and prayers
Hina Khan shared a new video on Instagram where she could be seen with a shaved head. The TV celebrity is going through a stage 3 breast cancer treatment
Multiple studies showed the potential of Artificial Intelligence in detecting cancers in advance. Advanced technology working on developing new drugs to predict the treatment outcome and prognosis
Around 26 per cent of cancer patients in India have tumours in the head and neck, and there is an upward trend of such cases in the country, a study has found. The findings of the study, conducted on 1,869 cancer patients across the country, were released on the World Head and Neck Cancer Day observed on Saturday. Cancer Mukt Bharat Foundation, a Delhi-based non-profit organisation, conducted the study by collating data from calls received on its helpline number from March 1 to June 30. Dr. Ashish Gupta, a senior oncologist who is heading the Cancer Mukt Bharat Campaign in India, said that India is seeing surge in head and neck cancer cases, especially among young men, due to increased tobacco consumption and human papillomavirus (HPV) infection. "Around 80-90 pc of oral cancer patients have been found to use tobacco in some form, be it smoking or chewing. Most of the head and neck cancer are preventable, unlike other cancers for which the reason is unknown. It is a preventable ..
Actor Hina Khan's recent stage 3 diagnosis underscores a concerning trend of breast cancer amongst younger women. So here's all about the breast cancer impacting overall survival and future recurrence
Hina Khan shocked her fans today after she announced that she had been diagnosed with stage 3 breast cancer; she added she is determined to overcome the disease
Breast cancer is now the world's most common carcinogenic disease, with the ailment likely to cause a million deaths a year by 2040, , a new Lancet commission has found. Around 7.8 million women were diagnosed with breast cancer in five years till the end of 2020 and about 685,000 women died from the disease the same year, it said. Globally, breast cancer cases will increase from 2.3 million in 2020 to more than 3 million by 2040, with low- and middle-income countries being "disproportionately affected", the commission estimated. By 2040, deaths due to the disease will be a million a year, it added. The Lancet report pointed to "glaring inequities" and suffering from symptoms, despair and financial burden due to breast cancer, which are often "hidden and inadequately addressed". Laying out recommendations for tackling these challenges in breast cancer, the commission suggested better communication between patients and health professionals as a crucial intervention that could impro
Enhertu, an antibody-drug conjugate, is being used in the treatment of HER2-positive metastatic breast cancer in a number of countries globally